Clinical Trials

NCT Number: NCT06193486 Phase: PHASE1 Trial Summary: This is a phase 1 single center clinical trial for patients with end stage Metastatic Castration Resistant Prostate Cancer who have progressed through standard of care treatment options and are on zol – see clinicaltrials.gov for information and location Clinicaltrials.gov Trial Sponsor(s): H. Lee Moffitt Cancer Center and […]

NCT Number: NCT06237179 Phase: PHASE1|PHASE2 Trial Summary: To test the preliminary effectiveness of a home-based exercise training (ET) intervention to improve exercise capacity (VO2 peak & 6-minute walk distance [6MWD]) among prostate cancer (PC) patients – see clinicaltrials.gov for information and location Clinicaltrials.gov Trial Sponsor(s): Virginia Commonwealth University Acronym: EXTRA-PC

NCT Number: NCT05918263 Phase: Trial Summary: The purpose of this study is to determine whether a 16-week, home-based, virtually supervised exercise program will slow cancer progression of prostate cancer among Black men with prostate cancer unde – see clinicaltrials.gov for information and location Clinicaltrials.gov Trial Sponsor(s): Dana-Farber Cancer Institute Acronym:

NCT Number: NCT05926102 Phase: Trial Summary: Prostate cancer is the most common non-skin cancer among Veterans and the second leading cause of male cancer death. Current methods of screening men for prostate cancer are inaccurate and cannot iden – see clinicaltrials.gov for information and location Clinicaltrials.gov Trial Sponsor(s): VA Office of Research and Development Acronym: […]

NCT Number: NCT05000294 Phase: Phase 1| Phase 2 Trial Summary: Checkpoint inhibitor therapy represents a significant advance in cancer care. The interaction between PD-1 and PD-L1 induces immune tolerance, and the inhibition of this interaction is an effective tr – see clinicaltrials.gov for information and location Clinicaltrials.gov Trial Sponsor(s): University of Florida Acronym:

NCT Number: NCT05056077 Phase: Trial Summary: This clinical trial studies the effect of four different intervention components “tools” on body weight, nutrition, and physical activity in cancer survivors. Studies indicate that people with a histo – see clinicaltrials.gov for information and location Clinicaltrials.gov Trial Sponsor(s): University of California, San Francisco Acronym: TTBF

NCT Number: NCT05650021 Phase: Trial Summary: The purpose of the study is to determine if a radiopaque hydrogel rectal spacer, SpaceOAR Vue®, can be used in place of fiducial markers when aligning patients for radiotherapy. The investigator hypo – see clinicaltrials.gov for information and location Clinicaltrials.gov Trial Sponsor(s): Milton S. Hershey Medical Center Acronym:

NCT Number: NCT05730712 Phase: Trial Summary: This phase II trial tests how well pertuzumab, trastuzumab, hyaluronidase-zzxf and enzalutamide works in treating patients with castration-resistant prostate cancer that has spread from where it first – see clinicaltrials.gov for information and location Clinicaltrials.gov Trial Sponsor(s): Mayo Clinic Acronym:

NCT Number: NCT05765500 Phase: Trial Summary: This study is testing the way that approved androgen deprivation therapy treatments, Leuprolide and Relugolix, for prostate cancer affect quality of life, blood levels, cholesterol, and blood sugar. T – see clinicaltrials.gov for information and location Clinicaltrials.gov Trial Sponsor(s): Dana-Farber Cancer Institute Acronym: